maaf email atau password anda salah

Kimia Farma’s Loss Due to Expired Vaccines

Monday, October 16, 2023

Kimia Farma and the holding of state-owned pharmaceutical companies have an excess stock of vaccines that are nearing their expiration date. The state could suffer losses.

arsip tempo : 171494603767.

People receive first dose of injection during the Gotong Royong Covid-19 Vaccination program organized by Perbanas in collaboration with Bio Farma and Kimia Farma at the Senayan Indoor Tennis Court, Jakarta, June 19, 2021. TEMPO / Hilman Fathurrahman W . tempo : 171494603767.

KIMIA Farma is enjoying a good time in business. In the first semester of 2023, the state-owned pharmaceutical company made an operating profit of Rp236.29 billion (around US$15.7 million). This achievement stands in contrast to the situation in the first semester of last year, when Kimia Farma suffered an operational loss of Rp15.67 billion (US$1 million). Kimia Farma Chief Executive Officer (CEO) David Utama said that the company could rec

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • April 29, 2024

  • April 22, 2024

  • April 15, 2024

  • April 4, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe